E. coli β-Gal x Human CD3 Bispecific Antibody - Negative Control

Control scFv antibody - Recombinant

ABOUT

Monoclonal scFv antibody against β-galactosidase and human CD3 - Negative control

Anti-βGal-hCD3 is a bispecific antibody that binds to two sites: E. coli β-galactosidase (β-Gal)and hCD3, part of the T cell receptor. It is used as a negative control for Anti-hCD19-CD3 bispecific antibody that, alike Blinatumomab, engages unstimulated T cells to proliferate and exert cytotoxic activity on CD19-positive lymphoma cells [1,2].

 

References:

1. Krishnamurthy A. & Jimeno A., 2017. Bispecific antibodies for cancer therapy: A review. Pharmacol Ther. S0163-7258(17)30293-0.
2. Bargou R. et al., 2008. Tumor Regression in Cancer Patients by Very Low Doses of a T Cell– Engaging Antibody. Science. 321(5891):974-7.

All products are for research use only, and not for human or veterinary use.

SPECIFICATIONS

Specifications

Target

CD3, β-Galactosidase

Target species

Human, E. coli

Applications

Negative control antibody

Species
Human
Escherichia coli
Isotype
None (scFv)
Tag
His6
Source
CHO cells
Purification
HisTrap affinity chromatography
Formulation buffer

Sodium phosphate buffer, saccharose

Preservative
Azide-free
Purity
> 90%
Appearance (form)
Lyophilized
Reconstitution buffer
Sterile water (not provided)
Endotoxin

Negative (tested using EndotoxDetect™ assay)

Tested applications

Cellular assays, ELISA, flow cytometry

Quality control

Each lot is validated by flow cytometry.

CONTENTS

Contents

  • Product: 
    Anti-βGal-hCD3
  • Cat code: 
    bimab-bgcd3-01
  • Quantity: 
    10 µg

Shipping & Storage

  • Shipping method:  Room temperature
  • Storage:

    • -20°C
    Stability: -20°C for up to 1 year

    Caution:

    • Avoid repeated freeze-thaw cycles

DOCUMENTS

Documents

Anti-βGal-hCD3

Technical Data Sheet

Validation Data Sheet

Safety Data Sheet

Certificate of analysis

Need a CoA ?

CUSTOMER SERVICE & TECHNICAL SUPPORT

Question about this product ?